Trident Texofab Stock Price Analysis and Quick Research Report. Is Trident Texofab an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Trident Texofab. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Trident Texofab has a PE ratio of 129.203071220545 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Trident Texofab has ROA of 1.3566% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Trident Texofab has a Current ratio of 1.2323.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Trident Texofab has a ROE of 6.8776%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Trident Texofab has a Debt to Equity ratio of 2.2752 which means that the company has high proportion of debt in its capital.

• Sales growth: Trident Texofab has reported revenue growth of 3.246% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Trident Texofab for the current financial year is 6.18746444130376%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Trident Texofab is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Trident Texofab is Rs 1.8885. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Trident Texofab in Ticker for free. Also, one can get the intrinsic value of Trident Texofab by using Valuation Calculators, which are available with a Finology ONE subscription. 

Trident Texofab FAQs

Q1. What is Trident Texofab share price today?
Ans: The current share price of Trident Texofab is Rs 244.

Q2. What is the market capitalisation of Trident Texofab?
Ans: Trident Texofab has a market capitalisation of Rs 365.8966416 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Trident Texofab?
Ans: The PE ratio of Trident Texofab is 129.203071220545 and the P/B ratio of Trident Texofab is 6.27567174121599, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Trident Texofab share?
Ans: The 52-week high share price of Trident Texofab is Rs 259, and the 52-week low share price of Trident Texofab is Rs 42.05.

Q5. Does Trident Texofab pay dividends?
Ans: Currently, Trident Texofab does not pay dividends. Dividend yield of Trident Texofab is around 0%.

Q6. What are the face value and book value of Trident Texofab shares?
Ans: The face value of Trident Texofab shares is Rs 10, while the book value per share of Trident Texofab is around Rs 38.8803. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Trident Texofab?
Ans: Trident Texofab has a total debt of Rs 36.9644 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Trident Texofab?
Ans: The ROE of Trident Texofab is 6.8776% and ROCE of Trident Texofab is 10.1061%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Trident Texofab a good buy for the long term?
Ans: The Trident Texofab long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Trident Texofab undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Trident Texofab appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Trident Texofab’s financials?
Ans: You can review Trident Texofab’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.